Ftse Mib
38.009,05
-0,78%
DAX
22.567,14
-0,44%
S&P 500
5.523,25
-1,36%
NASDAQ
17.249,11
-2,26%
Bitcoin
80.275,61
-4,07%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Axonics Inc (AXNX) Axonics Inc (AXNX) Notizie

Axonics Inc

AXNX
70,98
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202415:05EDGAR2Form 15-12G - Securities registration termination [Section..
21/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/11/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202414:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202414:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202414:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202414:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202414:58EDGAR2Form POS AM - Post-Effective amendments for registration..
15/11/202414:56EDGAR2Form S-8 POS - Securities to be offered to employees in..
15/11/202414:54EDGAR2Form 8-K - Current report
15/11/202414:43PRNUSBoston Scientific Closes Acquisition of Axonics, Inc.
13/11/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:03EDGAR2Form 8-K - Current report
07/11/202422:01BWAxonics Reports Third Quarter 2024 Financial Results
04/10/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202412:00BWAxonics Receives Regulatory Approval for Fourth-Generation..
19/9/202400:59BWAxonics Prevails in Patent Infringement Lawsuit with..
01/8/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:03EDGAR2Form 8-K - Current report
01/8/202422:01BWAxonics Reports Second Quarter 2024 Financial Results
16/5/202422:01BWAxonics Receives Regulatory Approval for Recharge-Free SNM..
30/4/202422:01BWAxonics Reports First Quarter 2024 Financial Results
24/4/202412:30PRNUSBoston Scientific Announces Results for First Quarter 2024
22/3/202421:01BWAxonics Stockholders Approve Merger Agreement with Boston..
21/3/202421:54BWAxonics Provides Update on Inter Partes Review Proceedings
14/3/202411:00BWAxonics Receives CE Mark Approval for Fourth-Generation..
Apertura: Min: Max:
Chiusura: 70,98

La tua Cronologia

NASDAQ
AXNX
Axonics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci